SEC Approves FINRA Rule 5123 Changes: Is Your Private Placement Really Exempt From Filing?

Key Question

When can a broker-dealer rely on an exemption from FINRA’s private-placement filing requirements, and does the SEC’s approval of expanded Rule 5123 exemptions simplify that determination?

Our View

The SEC’s approval modestly expands FINRA Rule 5123’s filing exemptions for broker-dealers, but compliance officers and senior management should not mistake the expansion for broader relief: FINRA’s recent examination findings demonstrate that determining – and documenting – whether an exemption actually applies remains a significant compliance risk.

Executive Summary

On July 24, 2026, the Securities and Exchange Commission approved FINRA’s amendments to Rules 5110 and 5123, including an expansion of the accredited-investor categories eligible for an exemption from Rule 5123’s private-placement filing requirements. The Rule 5123 amendment adds certain entities with more than $5 million in investments and certain family offices with more than $5 million in assets under management to the categories eligible to support the filing exemption. The change aligns FINRA’s rule more closely with the categories the SEC added to its accredited-investor definition in 2020.

For broker-dealers, however, the more important compliance issue may be what the amendment does not change. FINRA Rule 5123 generally requires firms selling securities in private placements to make specified filings with FINRA within 15 calendar days of the first sale unless an exemption applies. In its 2026 Annual Regulatory Oversight Report – Private Placements, FINRA identified firms that failed to file, filed late, or incorrectly relied on exemptions, including firms that misunderstood the distinction between institutional accredited investors covered by Rule 5123 and individual accredited investors, who generally are not.

Accordingly, the SEC’s approval should prompt firms not only to update their exemption matrices but also to examine how exemption determinations are made, supported, and supervised. Regardless of whether a Rule 5123 filing is required, the exemption does not eliminate a broker-dealer’s separate obligations related to reasonable investigation, Regulation Best Interest, suitability where applicable, communications, supervision, and other requirements governing private placements.

Regulatory Background

FINRA Rule 5123 is fundamentally a filing rule, not an exemption from the substantive regulatory obligations associated with selling private placements. Under Rule 5123(a), when a FINRA member sells a security in a non-public offering relying on an available Securities Act registration exemption, the firm generally must submit to FINRA a private placement memorandum, term sheet, or other offering document, as well as any retail communication (including e-mail transmittals) that promotes or recommends the private placement, including materially amended versions. If no such documents or communications were used, the firm must notify FINRA accordingly. The filing generally must be made within 15 calendar days after the date of first sale.

Rule 5123(b) contains several exemptions. Among them are offerings sold solely to specified categories of sophisticated or institutional investors, including institutional accounts, qualified purchasers, qualified institutional buyers, and specified categories of accredited investors. Before the newly approved amendment, Rule 5123(b)(1)(J) expressly covered accredited investors described in Securities Act Rule 501(a)(1), (2), (3), or (7). The SEC’s July 24, 2026 approval order approved adding Rule 501(a)(9) and (12) to that list.

Those categories were added to the accredited-investor definition in 2020. The SEC’s accredited investor guidance describes, among other categories, entities that hold investments of more than $5 million and qualifying family offices with assets under management exceeding $5 million. The family-office category also requires that the family office not be formed solely to acquire the offered securities and that the prospective investment be directed by a person with sufficient financial and business knowledge and experience to evaluate its merits and risks.

FINRA’s current Rule 5123 rulebook text now reflects the amendment by listing accredited investors described in Rule 501(a)(1), (2), (3), (7), (9), or (12), and by identifying the rule as amended by SR-FINRA-2026-002.

Practical Impact: The Exemption Analysis Still Matters

For compliance purposes, the amendment should be viewed as a targeted expansion rather than a broad accredited-investor exemption. That distinction is particularly important because FINRA’s examination findings indicate that firms are already making mistakes in this area.

   Accredited Investor Does Not Automatically Mean Rule 5123 Exempt. One of the most important distinctions under FINRA Rule 5123 is that not every accredited investor is a Rule 5123-exempt investor. Securities Act Rule 501(a) includes numerous categories of accredited investors, but Rule 5123 historically exempted only certain institutional categories, including investors qualifying under Rule 501(a)(1), (2), (3), and (7). The amendment to Rule 5123(b)(1)(J) expands the list to include certain entities that own more than $5 million in investments under Rule 501(a)(9) and qualifying family offices under Rule 501(a)(12). It does not create a blanket exemption for every natural person or entity that qualifies as an accredited investor under some other paragraph of Rule 501(a).

By contrast, an offering sold to an individual who qualifies as an accredited investor solely because of the familiar net-worth or income tests under Rule 501(a)(5) or (6) does not qualify for the Rule 5123 accredited-investor filing exemption. The same is true for several other accredited investor categories unless another separate Rule 5123 exemption applies. Accordingly, firms should avoid treating “accredited investor” as shorthand for the conclusion that no filing is required.

That distinction is more than technical. FINRA’s 2026 oversight findings specifically identify firms that relied on the exemption for certain institutional accredited investors, even though it was generally not applicable to sales to individual accredited investors. The practical compliance point is simple: accredited-investor status answers a Securities Act eligibility question; Rule 5123 exemption status answers a separate FINRA filing question. Firms should identify the specific Rule 501(a) category relied upon, confirm that the category is covered by Rule 5123, and document the basis for the exemption before deciding not to file.

   FINRA Is Already Finding Incorrect Exemption Determinations. This is not merely a technical concern. In its 2026 oversight report, FINRA identified inadequate private-placement filing procedures, including failures to file, untimely filings with delays of six to twelve months in some cases, and reliance on Rule 5123(b) exemptions that did not apply. The finding makes exemption analysis itself a supervisory issue, not simply a filing-department issue.

   Exemption Determinations Should Be Documented, Not Assumed. A firm’s supervisory file should enable a reviewer to understand why the firm concluded that a filing was or was not required. For an entity relying on Rule 501(a)(9), that may include documentation supporting the nature of the entity, the amount and character of its investments, and whether it was formed for the specific purpose of acquiring the offered securities.

For a family office relying on Rule 501(a)(12), the analysis involves more than confirming that the words “family office” appear on an investor questionnaire. As described in the SEC’s small-business compliance guide, the category includes an assets-under-management threshold and additional conditions regarding the purpose of formation and the sophistication of the person directing the investment. Documentation should therefore support the specific exemption being relied upon, rather than simply state that the purchaser is an accredited investor.

   Filing Relief Is Not Due-Diligence Relief. Perhaps the most important operational point is that an exemption from Rule 5123 filing does not eliminate the substantive obligations associated with recommending or selling a private placement. FINRA’s 2026 private-placement guidance emphasizes reasonable investigation; Regulation Best Interest for recommendations to retail customers; FINRA Rule 2111 for recommendations to non-retail customers, where applicable; and other potentially applicable requirements, including Rules 2210, 3110, 3280, 5122, and 5123.

FINRA also reiterates that a reasonable investigation of a recommended privately offered security should, at a minimum, evaluate the issuer and its management, the issuer’s business prospects, assets, claims being made, and intended use of proceeds. The compliance implication is straightforward: “exempt from filing” should never become shorthand for “exempt from review.”

Recommended Actions

The approved amendment gives firms an opportunity to update Rule 5123 procedures and to test the broader controls for identifying, documenting, and supervising private-placement filing obligations.

  • Update the Rule 5123 Exemption Matrix. Revise written procedures, checklists, and other compliance tools to incorporate Rules 501(a)(9) and (12) and to clearly distinguish those institutional categories from natural-person accredited investors.
  • Require Documented Exemption Determinations. Private-placement files should identify the specific subsection of Rule 5123(b) being relied upon and contain sufficient information to demonstrate why the exemption applies. A generic notation such as “accredited investors only” may not establish that a Rule 5123 filing exemption exists.
  • Review Investor Classification Controls. Evaluate how investor status is determined from subscription documents or investor questionnaires and incorporated into the firm’s Rule 5123 determination. The process should distinguish between accredited investors, institutional accounts, qualified purchasers, qualified institutional buyers, and other categories rather than treating these terms interchangeably.
  • Build Filing Controls Around the Date of First Sale. When no exemption applies, procedures should identify the date of first sale and track the 15-calendar-day filing deadline. FINRA’s recent findings on late filings underscore the need for operational control rather than informal reminders.
  • Test the Process. Compliance testing should sample both filed and non-filed private placements. Testing only whether filings were timely will not identify offerings for which the firm incorrectly concluded that no filing was required.
  • Maintain Due Diligence and Supervisory Review Regardless of Filing Status. Keep the Rule 5123 exemption determination separate from reasonable-investigation, Reg BI, suitability, communications, and supervisory analyses. An offering’s exemption from FINRA filing does not establish that the security is appropriate to recommend or that the firm’s investigation is sufficient.

Key Takeaways

The SEC’s approval gives broker-dealers additional flexibility in filing under Rule 5123, but the practical compliance lesson extends beyond the two newly covered investor categories. Firms should treat the amendment as an opportunity to verify that their entire exemption-determination process is defensible.

  • The Rule 5123 exemption has expanded. Rule 5123(b)(1)(J) now includes accredited investors described in Rules 501(a)(9) and (12), as well as certain entities that hold investments exceeding $5 million and certain qualifying family offices with more than $5 million in assets under management.
  • Not every accredited investor creates a filing exemption. The amendment does not make Rule 5123 a blanket exemption for offerings sold to accredited investors. Firms must determine which Rule 501 category applies and whether that category is listed in Rule 5123(b)(1)(J).
  • Documentation is part of the compliance defense. FINRA has expressly identified firms that improperly rely on Rule 5123 exemptions. Firms should be able to reconstruct and support the exemption analysis from their books and records.
  • The 15-day filing obligation remains important. If no exemption applies, Rule 5123 generally requires filing within 15 calendar days of the first sale.
  • Filing exemptions do not eliminate substantive obligations. Private-placement due diligence, Regulation Best Interest, suitability where applicable, communications, and supervision remain separate issues even when the offering qualifies for a Rule 5123 filing exemption.

Conclusion

The SEC’s approval of the Rule 5123 amendment is a targeted modernization that brings FINRA’s filing exemptions into closer alignment with the SEC’s expanded accredited-investor framework. For firms selling private placements, however, the compliance significance extends beyond the two new exemption categories.

FINRA’s examination findings demonstrate that the regulator is already focused on whether firms understand the boundaries of Rule 5123 and apply its exemptions correctly. The stronger compliance approach is therefore not simply to add two categories to an exemption checklist. Firms should be able to demonstrate who made the exemption determination, which provision supports it, what information was reviewed, and how the firm confirmed that the applicable conditions were satisfied.

The amendment may reduce filing obligations for some institutional private placements. It does not reduce the need for a defensible supervisory process.